Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Chemsex and recreational drug use news

Show

From To
Infection with multi-drug resistant virus is lifelong, Canadian expert argues

Patients infected with HIV resistant to all three widely used classes of antiretrovirals will keep that resistance for life, and not revert back to wild

Published
17 November 2004
By
Gus Cairns
Higher than expected incidence of HIV found in injecting drug users in London

A higher than expected incidence of HIV infections, and a high incidence of hepatitis C virus infections has been found amongst injecting drug users in

Published
12 November 2004
By
Michael Carter
HIV-positive former IDUs have poorer immune response to HAART

Former injecting drug users are significantly less likely to experience a good immunological response to highly active antiretroviral therapy (HAART), even with sustained suppression of

Published
11 November 2004
By
Michael Carter
ICAAC: Rapid HIV disease progression in injecting drug users in Ukraine

Over two-thirds of a cohort of HIV-positive injecting drug users in the Ukraine had progressed to AIDS, and over a half had died within five

Published
02 November 2004
By
Michael Carter
More opportunistic infections seen in women cocaine and opiate users, but no effect of drug use on CD4s or viral load

Women using cocaine, heroin or methadone or injecting any drugs had 65% more AIDS-defining illnesses over a five-year period, according to a large prospective study

Published
19 October 2004
By
Gus Cairns
Abacavir/3TC once daily pill gets scientific approval as Kivexa in Europe

GlaxoSmithKline’s once daily fixed dose combination of abacavir and 3TC (lamivudine) has received scientific approval from the European Medicines Agency, it was announced on Friday. The

Published
20 September 2004
By
Keith Alcorn
Higher immune system activation prior to seroconversion leads to faster CD4 T-cell loss

Patients with a history of high immune system activation before HIV infection experience faster declines in CD4 cell counts, according to a prospective cohort study

Published
17 September 2004
By
Christopher Gadd
Injecting users may need to start treatment earlier than other HIV+ people, US study reports

HIV-positive injecting drug users need to commence HAART when their CD4 cell count is above 350 cells/mm3, a level substantially higher than that recommended by

Published
08 September 2004
By
Michael Carter
French IV drug users who report HAART side-effects have more risky sex

The perception of having adverse side-effects due to one’s HAART regime was the strongest single predictor of unsafe sexual behaviour among a cohort of French

Published
08 June 2004
By
Gus Cairns
Large number of young Canadian injecting drug users coinfected with HIV and HCV

A high proportion of injecting drug users under the age of 29 in one of Canada’s largest cities are coinfected with HIV and hepatitis C

Published
25 May 2004
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.